Earnings Feed
Start Free
Home/Filings/4/0001855763-22-000013
4//SEC Filing

Baxter Nicholas W 4

Accession 0001855763-22-000013

CIK 0001348362other
View on SEC.govCompany Profile

Filed

Oct 12, 8:00 PM ET

Accepted

Oct 13, 12:49 PM ET

Size

10.6 KB

Accession

0001855763-22-000013

Insider Transaction Report

Form 4
Period: 2022-10-12
Lexaria Bioscience Corp.LEXX
Baxter Nicholas W
Director
Transactions
  • Award

    Stock Options

    2022-10-12+18,200→ 30,000 total
    Exercise: $1.96From: 2022-10-12Exp: 2027-10-12→ Common Shares (18,200 underlying)
Holdings

  • Stock Options

    Exercise: $5.31From: 2021-04-26Exp: 2026-04-26→ Common Shares (1,500 underlying)
    1,500

  • Stock Options

    Exercise: $7.08From: 2021-06-08Exp: 2026-06-08→ Common Shares (5,000 underlying)
    6,500

  • common shares

    11,000

  • Stock Options

    Exercise: $6.23From: 2021-09-01Exp: 2026-09-01→ Common Shares (1,900 underlying)
    8,400

  • Stock Options

    Exercise: $3.39From: 2022-03-08Exp: 2027-03-08→ Common Shares (3,400 underlying)
    11,800

Documents

1 file

Issuer

Lexaria Bioscience Corp.

CIK 0001348362

→
Entity typeother

Related Parties

1
  • filerCIK 0001312326

Filing Metadata

Form type
4
Filed
Oct 12, 8:00 PM ET
Accepted
Oct 13, 12:49 PM ET
Size
10.6 KB
View on SEC.gov